The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

Latest News

Laure Gossec, MD, PhD, Professor of Rheumatology, Pitié-Salpêtrière Hospital and Sorbonne University - Pierre et Marie Curie Campus, Paris, France.
Real-World Study Confirms Similar Efficacy of Guselkumab and IL-17i for PsA

November 30th 2024

Findings from PsABIOnd can help reassure clinicians of similar efficacy between treatment choices.

PEGylated Uricase Well-Tolerated, Demonstrates Dose-Dependent Urate-Lowering
PEGylated Uricase Well-Tolerated, Demonstrates Dose-Dependent Urate-Lowering

November 28th 2024

Zahi Touma, MD, PhD, director, Toronto Lupus Program and Associate Professor of medicine, department of medicine, division of rheumatology, Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto
Anifrolumab Delayed Onset of Organ Damage in Patients With SLE

November 27th 2024

 Lihi Eder, MD, associate professor of medicine, Women’s College Hospital and University of Toronto, Canada
Guselkumab Similarly Efficacious Among Male, Female Patients With PsA

November 26th 2024

Urate-Lowering Therapy Remains Tolerable in Patients with Gout, CKD | Image Credit: ResearchGate
Urate-Lowering Therapy Remains Tolerable in Patients with Gout, CKD

November 25th 2024

Latest CME Events & Activities

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

Shaping the Management of COPD with Biologic Therapy

View More

Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease

View More

Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis

View More

Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD

View More

A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology

View More

Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age

View More

Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis

View More

Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care

View More

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

View More

Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy

View More

More News

© 2024 MJH Life Sciences

All rights reserved.